Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Rhaeos
AddedFeb 15, 2024
UpdatedJun 18, 2026
Rhaeos

Rhaeos

Rhaeos develops FlowSense, a noninvasive, wearable skin patch for subdermal fluid monitoring, targeting hydrocephalus.

HQ
Evanston, IL, US
Founded
2018
Overview
Compare
Fundraising
Employees
Website

Rhaeos is a VC backed, clinical stage medical device company developing FlowSense, a platform technology and a noninvasive wireless, wearable skin patch that can assess and monitor fluid flow subdermally throughout the body.

The company is initially targeting hydrocephalus, a life threatening condit... Read more

Rhaeos - Similar Companies

Hemorai logo

Hemorai

hemorai.com

BioSensys logo

BioSensys

PyrAmes logo

PyrAmes

pyrameshealth.com

Neurava logo

Neurava

GraphWear Technologies logo

GraphWear Technologies

CoraVie Medical logo

CoraVie Medical

coraviemedical.com

ivWatch logo

ivWatch

ivwatch.com

Senseer Health logo

Senseer Health

senseer.us

InnerSpace NeuroSolutions logo

InnerSpace NeuroSolutions

Zorro Flow logo

Zorro Flow

zorro-flow.com

V-Sense Medical logo

V-Sense Medical

BioSense logo

BioSense

thebiosense.com

BeckerSmith Medical logo

BeckerSmith Medical

Physia logo

Physia

Ryah Group logo

Ryah Group

ryah.com

Rhaeos - Quick Facts

Who are Rhaeos' competitors?

Companies similar to Rhaeos include Hemorai, BioSensys, PyrAmes and Neurava.

When was Rhaeos founded?

Rhaeos was founded in 2018.

Where is Rhaeos' headquarters located?

Rhaeos' headquarters is located in Evanston, IL, US.

When was Rhaeos' last funding round?

Rhaeos' most recent funding round was for $1.5M (USD) in October 2023.

How much has Rhaeos raised to-date?

As of Oct 9, 2023, Rhaeos has raised a total of $19.6M (USD).

How many employees does Rhaeos have?

Rhaeos has 26 employees as of Feb 5, 2024.

Rhaeos - Classification

Industry
  • Hardware
Ownership
  • Venture Capital
Technology
  • Wearable Technology
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Medical Devices
Tags
  • Healthcare
  • Healthtech
  • IoT
  • Medical
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 7 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified